Most of these colitis models confirm the protective effect of the ghrelin system on the inflammation-damaged intestinal mucosa, which may have clinical implications (reducing inflammation, indirect anti-cancer effects, or an additional form of therapy for these conditions). This evidence concerns the gene GHRL and colitis.